Varma Mutual Pension Insurance Co Sells 2,700 Shares of HCA Healthcare, Inc. $HCA

Varma Mutual Pension Insurance Co reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 27,563 shares of the company’s stock after selling 2,700 shares during the quarter. Varma Mutual Pension Insurance Co’s holdings in HCA Healthcare were worth $12,868,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Palisade Asset Management LLC acquired a new position in shares of HCA Healthcare in the third quarter worth approximately $26,000. Holos Integrated Wealth LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth approximately $29,000. Ares Financial Consulting LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth approximately $31,000. JPL Wealth Management LLC acquired a new position in shares of HCA Healthcare in the third quarter worth approximately $33,000. Finally, Aventura Private Wealth LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth approximately $34,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the sale, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This trade represents a 16.06% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 13,714 shares of company stock worth $7,050,460. 1.50% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on HCA shares. Wells Fargo & Company dropped their price target on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research note on Monday, April 27th. Mizuho boosted their price target on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. JPMorgan Chase & Co. boosted their price target on HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Finally, TD Cowen dropped their price target on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $517.82.

HCA Healthcare Stock Down 1.2%

NYSE HCA opened at $427.71 on Tuesday. The company has a market cap of $94.88 billion, a price-to-earnings ratio of 14.71, a P/E/G ratio of 1.37 and a beta of 1.18. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The business has a 50 day moving average price of $497.66 and a 200-day moving average price of $486.41.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.05 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.